| Literature DB >> 11437407 |
J H de Witte1, J A Foekens, N Brünner, J J Heuvel, T van Tienoven, M P Look, J G Klijn, A Geurts-Moespot, N Grebenchtchikov, T Benraad, C G Sweep.
Abstract
Using a previously developed enzyme-linked immunosorbent assay (ELISA), the levels of the receptor for urokinase-type plasminogen activator (uPAR) were determined in cytosols and corresponding membrane pellets derived from 878 primary breast tumours. The levels of uPAR in the pellet extracts were more than 3-fold higher than those measured in the cytosols (P< 0.001). Moreover, the uPAR levels in the two types of extracts were weakly, though significantly, correlated with each other (rS= 0.20, P< 0.001). In Cox univariate analysis, high cytosolic levels of uPAR were significantly associated with reduced overall survival (OS) and relapse-free survival (RFS). The levels of uPAR in pellet extracts appeared not to be related with patient survival. In multivariate analysis, elevated levels of uPAR measured in cytosols and pellet extracts were found to be independent predictors of poor OS, not RFS. The prediction of poor prognosis on the basis of high uPAR levels emphasizes its important role in plasmin-mediated degradation of extracellular matrix proteins during cancer invasion and metastasis. Copyright 2001 Cancer Research Campaign.Entities:
Mesh：
Substances：
Year: 2001 PMID： 11437407 PMCID： PMC2363926 DOI： 10.1054/bjoc.2001.1867
Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640